Eurasian Journal of Medical and Natural Sciences 5-jild 2-son (2025) · 91–99-betlar
ANALYSIS OF THE RANGE OF DRUGS USED FOR URILOSIS DISEASE ON THE PHARMACEUTICAL MARKET OF THE REPUBLIC OF UZBEKISTAN
Maksudova, Firuza, Javliyeva, O’g’iloy, Raximova, Gulnora, Raximova, Oygul
Annotatsiya
Nephrolithiasis is a urological disorder characterized by the formation of calculi (kidney stones) in the renal and urinary tract. This study examines the composition, availability, dosage forms, and cost analysis of nephrolithiasis medications in [Country Name] through a systematic review. The market share of foreign medications declined from 58.34% to 42.85%, while domestic pharmaceutical manufacturers increased their share from 25% to 28.57%, and CIS-based manufacturers from 16.67% to 28.57%. However, the total volume of available medications remained relatively stable. Tablets and capsules account for 33.3% of the total nephrolithiasis medications, all of which are produced by foreign or CIS-based manufacturers.
Kidney stones, sodium citrate, potassium bicarbonate, citric acid, uric acid, salts, metabolic diseases, crystalluria.Почечнокаменная болезнь, цитрат натрия, бикарбонат калия, лимонная кислота, мочевая кислота, соли, метаболические заболевания, кристаллурия.Buyrak-tosh kasalligi, natriy sitrat, kaliy gidrokarbonat, limon kislotali, siydik kislotasi, tuzlar, metabolik kasallik, kristalluriya.
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.